[Waterhouse-Friederichsen syndrome, Sanarelli-Shwartzman phenomenon and Kasabach-Merritt syndrome].
D000614:Aminocaproates / Q000627:therapeutic use; D002648:Child; D006391:Hemangioma / Q000188:drug therapy / Q000473:pathology*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D011696:Purpura, Thrombocytopenic / Q000188:drug therapy / Q000473:pathology*; D012790:Shwartzman Phenomenon / Q000188:drug therapy / Q000473:pathology*; D012878:Skin Neoplasms / Q000188:drug therapy / Q000473:pathology*; D014884:Waterhouse-Friderichsen Syndrome / Q000188:drug therapy / Q000473:pathology*
D000614:Aminocaproates; D006493:Heparin
Waterhouse-Friderichsen-Syndrom, Sanarelli-Shwartzman-Phänomen und Kasabach-Merritt-Syndrom.